{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:30:13Z","timestamp":1783924213163,"version":"3.55.0"},"reference-count":227,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Vaccines"],"abstract":"<jats:p>When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in 2014; successful global eradication was anticipated within years. Transmission was interrupted in Nigeria after implementing innovative activities; unfortunately, transmission in Afghanistan and Pakistan has continued into 2025. An additional challenge has been controlling outbreaks and interrupting persistent transmission of circulating vaccine-derived poliovirus type 2 detected after global withdrawal of the use of Sabin strain type 2 oral poliovirus vaccine. The impediments to progress since 2014 are detailed and the challenges that the GPEI must successfully mitigate are reviewed herein. Primary challenges since the acute phase of the COVID-19 pandemic include the loss of a sense of urgency and political will\/national ownership in stopping poliovirus transmission, lower childhood routine immunization coverage and the decreased quality of outbreak response campaigns. These facets need to be strengthened. Ongoing security challenges require continued vigilance in affected areas of wild poliovirus-endemic countries as well as in countries with persistent transmission of vaccine-derived poliovirus. Eradication can be achieved if the multiple challenges mentioned are urgently and more effectively mitigated. Decreased funding for the GPEI in 2025 represents the primary, acute challenge that, if not urgently addressed, may allow for the reversal of all progress to date.<\/jats:p>","DOI":"10.3390\/vaccines13101060","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:33:50Z","timestamp":1760686430000},"page":"1060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impediments to Progress Toward Polio Eradication During 2014\u20132024: Effectively Addressing the Current Challenges"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-0957","authenticated-orcid":false,"given":"Steven","family":"Wassilak","sequence":"first","affiliation":[{"name":"Independent Researcher, Atlanta, GA 30307, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-3975","authenticated-orcid":false,"given":"Abdinoor","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3343-1347","authenticated-orcid":false,"given":"John","family":"Bigouette","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (1988). Forty-First World Health Assembly Resolutions and Decisions, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/164197\/WHA41_1988-REC-1_eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_2","unstructured":"Global Polio Eradication Initiative (2013). Polio Eradication & Endgame Strategic Plan 2013\u20132018. WHO\/POLIO\/13.02. World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_US.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/infdis\/jiu456","article-title":"Progress toward global interruption of wild poliovirus transmission, 2010\u20132013, and tackling the challenges to complete eradication","volume":"210","author":"Wassilak","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_4","unstructured":"Global Polio Eradication Initiative (2014). Annual Report 2014: On the Threshold of a Polio-Free World, World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/05\/GPEI_AR2014_EN.pdf."},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (2013). Progress toward eradication of polio\u2014Worldwide, January 2011\u2013March 2013. MMWR Morb. Mortal. Wkly. Rep., 62, 335\u2013338."},{"key":"ref_6","unstructured":"Global Polio Eradication Initiative (2025, September 04). Global Eradication of Wild Poliovirus Type 2 Declared: Declaration Further Milestone for Globally-Coordinated Vaccine Switch in 2016. Press Release 20 September. Available online: https:\/\/polioeradication.org\/news\/global-eradication-of-wild-poliovirus-type-2-declared\/."},{"key":"ref_7","unstructured":"Global Polio Eradication Initiative (2025, September 04). Two out of Three Wild Poliovirus Strains Eradicated: Global Eradication of Wild Poliovirus Type 3 Declared on World Polio Day. Press Release 24 October. Available online: https:\/\/polioeradication.org\/news\/two-out-of-three-wild-poliovirus-strains-eradicated\/."},{"key":"ref_8","first-page":"941","article-title":"Polio-free certification and lessons learned\u2014South-East Asia region, March 2014","volume":"63","author":"Bahl","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiu383","article-title":"A world without polio","volume":"210","author":"Cochi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15585\/mmwr.mm6432a5","article-title":"Progress Toward Poliomyelitis Eradication\u2014Nigeria, January 2014\u2013July 2015","volume":"64","author":"Etsano","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_11","unstructured":"Global Polio Eradication Initiative (2025, September 04). GPEI Applauds WHO African Region for Wild Polio-Free Certification. Support from National Governments and Global Donors Critical to the Region\u2019s Success Against Wild Polio and Must Continue to Achieve a Polio-Free World. Press Release 25 Augest. Available online: https:\/\/polioeradication.org\/news\/global-polio-eradication-initiative-applauds-who-african-region-for-wild-polio-free-certification\/."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.15585\/mmwr.mm7349a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2023\u2013September 2024","volume":"73","author":"Hardy","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.15585\/mmwr.mm7149a1","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2021\u2013September 2022","volume":"71","author":"Mohamed","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.15585\/mmwr.mm7238a1","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2022\u2013June 2023","volume":"72","author":"Bjork","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.15585\/mmwr.mm7039a1","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2020\u2013July 2021","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.15585\/mmwr.mm7142a1","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2021\u2013July 2022","volume":"71","author":"Mbaeyi","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15585\/mmwr.mm7233a1","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2022\u2013June 2023","volume":"72","author":"Mbaeyi","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.15585\/mmwr.mm7336a2","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2023\u2013June 2024","volume":"73","author":"Mbaeyi","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine-Worldwide, 2016","volume":"65","author":"Hampton","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jix117","article-title":"Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future","volume":"216","author":"Patel","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/infdis\/jiw592","article-title":"Polio Endgame: Lessons Learned From the Immunization Systems Management Group","volume":"216","author":"Zipursky","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1093\/infdis\/jiw626","article-title":"Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective","volume":"216","author":"Farrell","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1016\/j.vaccine.2022.08.008","article-title":"Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020","volume":"41","author":"Macklin","year":"2023","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"ref_25","unstructured":"Molodecky, N.A., and Sutter, R.W. (2025, September 04). Evaluation of the 2016 Switch from tOPV to bOPV. 30 September 2024. Lessons Learned and Implications for an Anticipated bOPV Cessation. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/11\/Switch-Report-20240930.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2023\u2013June 2024","volume":"73","author":"Greene","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.15585\/mmwr.mm6643a6","article-title":"Update on Vaccine-Derived Polioviruses-Worldwide, January 2016\u2013June 2017","volume":"66","author":"Jorba","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(19)31279-6","article-title":"The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: A double-blind, single-centre phase 1 study","volume":"394","author":"Bandyopadhyay","year":"2019","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(22)02397-2","article-title":"Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: A randomised, controlled, phase 2 clinical trial","volume":"401","author":"Zaman","year":"2023","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)32540-X","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: Two clinical trials","volume":"397","author":"Bandyopadhyay","year":"2021","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S1473-3099(22)00582-5","article-title":"A novel tool to eradicate an ancient scourge: The novel oral polio vaccine type 2 story","volume":"23","author":"Bandyopadhyay","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_32","unstructured":"World Health Organization (2025, September 04). Novel Oral Polio Vaccine Type 2 (nOPV2) Granted EUL Recommendation. WHO Has Issued an Emergency Use Listing Recommendation for the Type 2 Novel Oral Polio Vaccine (nOPV2). Press Release 13 November. Available online: https:\/\/polioeradication.org\/news\/novel-oral-polio-vaccine-type-2-nopv2-granted-interim-emergency-use-listing-recommendation\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.11604\/pamj.supp.2023.45.2.38033","article-title":"Deployment of novel oral polio vaccine type 2 under emergency use listing in Nigeria: The rollout experience","volume":"45","author":"Asekun","year":"2023","journal-title":"Pan Afr. Med. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.15585\/mmwr.mm7049a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2020\u2013June 2021","volume":"70","author":"Alleman","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_35","unstructured":"World Health Organization (2020). Contributions of the Polio Network to the COVID-19 Response: Turning the Challenge into an Opportunity for Polio Transition, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240011533."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2021.10.028","article-title":"The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities","volume":"41","author":"Burkholder","year":"2021","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"A93","DOI":"10.1016\/j.vaccine.2021.09.037","article-title":"Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic","volume":"41","author":"Molodecky","year":"2023","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.15585\/mmwr.mm695152a4","article-title":"Impact of COVID-19 Pandemic on Global Poliovirus Surveillance","volume":"69","author":"Zomahoun","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.vaccine.2021.04.026","article-title":"The impact of disruptions caused by the COVID-19 pandemic on global polio eradication","volume":"41","author":"Kalkowska","year":"2023","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lopez Cavestany, R., Eisenhawer, M., Diop, O.M., Verma, H., Quddus, A., and Mach, O. (2024). The Last Mile in Polio Eradication: Program Challenges and Perseverance. Pathogens, 13.","DOI":"10.3390\/pathogens13040323"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jiac130","article-title":"Polio by the Numbers\u2014A Global Perspective","volume":"226","author":"Badizadegan","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14760584.2024.2361060","article-title":"Evolution of global polio eradication strategies: Targets, vaccines, and supplemental immunization activities (SIAs)","volume":"23","author":"Thompson","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/INF.0000000000004330","article-title":"Polio Eradication: Status, Struggles and Strategies","volume":"43","author":"Bandyopadhyay","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_44","unstructured":"Global Polio Eradication Initiative (2025, September 04). Polio Eradication Strategy 2022\u20132026: Delivering on a Promise. Available online: https:\/\/iris.who.int\/handle\/10665\/345967."},{"key":"ref_45","unstructured":"Independent Montoiring Board (2023). 22nd Report. Closing in on Zero: Adapting to Complexity and Risk to the Path to End Polio, World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/05\/22nd-Report-of-The-Independent-Monitoring-Board-IMB.pdf."},{"key":"ref_46","unstructured":"Independent Monitoring Board (2024). 23rd Report. The Long Goodbye: Poliovirus Continues to Resist Extinction, World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/09\/23rd-IMB-Report-20240922.pdf."},{"key":"ref_47","unstructured":"Orenstein, W.A., Offit, P.A., Edwards, K.M., and Plotkin, S.A. (2023). Poliovirus Vaccine-Live. Vaccines, Elsevier. [8th ed.]."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.15585\/mmwr.mm7313a1","article-title":"Surveillance To Track Progress Toward Polio Eradication\u2014Worldwide, 2022\u20132023","volume":"73","author":"Kishore","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.jvacx.2020.100059","article-title":"New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators","volume":"4","author":"VanderEnde","year":"2020","journal-title":"Vaccine X"},{"key":"ref_50","unstructured":"Global Polio Eradication Initiative (2025, September 04). Guidelines on Environmental Surveillance for Detection of Polioviruses. Working Draft; March, 2015. Available online: http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/GPLN_GuidelinesES_April2015.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2005.02.002","article-title":"Environmental surveillance of wild poliovirus circulation in Egypt\u2014Balancing between detection sensitivity and workload","volume":"126","author":"Hovi","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S095026881000316X","article-title":"Role of environmental poliovirus surveillance in global polio eradication and beyond","volume":"140","author":"Hovi","year":"2012","journal-title":"Epidemiol. Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1093\/infdis\/jiu384","article-title":"Environmental surveillance for polioviruses in the Global Polio Eradication Initiative","volume":"210","author":"Asghar","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cowger, T.L., Burns, C.C., Sharif, S., Gary, H.E., Iber, J., Henderson, E., Malik, F., Zahoor Zaidi, S.S., Shaukat, S., and Rehman, L. (2017). The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan\u20142011\u20132013. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180608"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly, K.M., Verity, R., Durry, E., Asghar, H., Sharif, S., Zaidi, S.Z., Wadood, M.Z.M., Diop, O.M., Okayasu, H., and Safdar, R.M. (2018). Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: An observational study. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3070-4"},{"key":"ref_56","unstructured":"Global Polio Eradication Initiative (2022). Standard Operating Procedures: Responding to a Poliovirus Event or Outbreak Version 4, World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/05\/9789240049154-eng.pdf."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1128\/JVI.02354-07","article-title":"Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range","volume":"82","author":"Jorba","year":"2008","journal-title":"J. Virol."},{"key":"ref_58","unstructured":"Centers for Disease Control and Prevention (2006). Resurgence of wild poliovirus type 1 transmission and consequences of importation\u201421 countries, 2002\u20132005. MMWR Morb. Mortal. Wkly. Rep., 55, 145\u2013150."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly, K.M., Lamoureux, C., Molodecky, N.A., Lyons, H., Grassly, N.C., and Tallis, G. (2017). An assessment of the geographical risks of wild and vaccine-derived poliomyelitis outbreaks in Africa and Asia. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2443-4"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1093\/infdis\/jit454","article-title":"Outbreaks of paralytic poliomyelitis during 1996\u20132012: The changing epidemiology of a disease in the final stages of eradication","volume":"210","author":"Mach","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1093\/infdis\/jit234","article-title":"Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: Analysis of contact and enhanced community surveillance, 2009","volume":"210","author":"Mach","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.vaccine.2011.03.034","article-title":"Poliomyelitis outbreaks in Angola genetically linked to India: Risk factors and implications for prevention of outbreaks due to wild poliovirus importations","volume":"29","author":"Kidd","year":"2011","journal-title":"Vaccine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6925a4","article-title":"Progress Toward Polio Eradication\u2014Worldwide, January 2018\u2013March 2020","volume":"69","author":"Chard","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.15585\/mmwr.mm7123a3","article-title":"Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection-Malawi, February 2022","volume":"71","author":"Davlantes","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.15585\/mmwr.mm7215a3","article-title":"Update on Wild Poliovirus Type 1 Outbreak-Southeastern Africa, 2021\u20132022","volume":"72","author":"Davlantes","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_66","unstructured":"Centers for Disease Control and Prevention (2011). Progress toward poliomyelitis eradication\u2014Nigeria, January 2010\u2013June 2011. MMWR Morb. Mortal. Wkly. Rep., 60, 1053\u20131057."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/jiu318","article-title":"Progress toward poliomyelitis eradication in Nigeria","volume":"210","author":"Ado","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Upfill-Brown, A.M., Voorman, A., Chabot-Couture, G., Shuaib, F., and Lyons, H.M. (2016). Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria. BMC Med., 14.","DOI":"10.1186\/s12916-016-0600-z"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15585\/mmwr.mm6607a2","article-title":"Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas-Nigeria, 2016","volume":"66","author":"Nnadi","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11604\/pamj.supp.2023.45.2.39332","article-title":"Historical reconstruction of inaccessibility status in Local Government Areas (LGAs) of Borno and Yobe States, Nigeria, 2010\u20132020","volume":"45","author":"Forbi","year":"2023","journal-title":"Pan Afr Med J"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/jit285","article-title":"Using geographic information systems to track polio vaccination team performance: Pilot project report","volume":"210","author":"Gammino","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/infdis\/jiu010","article-title":"Improving polio vaccination coverage in Nigeria through the use of geographic information system technology","volume":"210","author":"Barau","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1093\/infdis\/jiv493","article-title":"Tracking Vaccination Teams During Polio Campaigns in Northern Nigeria by Use of Geographic Information System Technology: 2013\u20132015","volume":"213","author":"Touray","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15585\/mmwr.mm6708a5","article-title":"Progress Toward Poliomyelitis Eradication\u2014Nigeria, January\u2013December 2017","volume":"67","author":"Bolu","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"642","DOI":"10.15585\/mmwr.mm6829a3","article-title":"Progress Toward Poliomyelitis Eradication\u2014Nigeria, January 2018\u2013May 2019","volume":"68","author":"Adamu","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12942-019-0175-y","article-title":"Finding inhabited settlements and tracking vaccination progress: The application of satellite imagery analysis to guide the immunization response to confirmation of previously-undetected, ongoing endemic wild poliovirus transmission in Borno State, Nigeria","volume":"18","author":"Higgins","year":"2019","journal-title":"Int. J. Health Geogr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13031-022-00452-2","article-title":"Conducting public health surveillance in areas of armed conflict and restricted population access: A qualitative case study of polio surveillance in conflict-affected areas of Borno State, Nigeria","volume":"16","author":"Wiesen","year":"2022","journal-title":"Confl. Health"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/infdis\/jix175","article-title":"Approaches to Vaccination Among Populations in Areas of Conflict","volume":"216","author":"Nnadi","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_79","first-page":"289","article-title":"Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal. Off. Publ. Soc. Risk Anal."},{"key":"ref_80","first-page":"303","article-title":"Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal. Off. Publ. Soc. Risk Anal."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1093\/infdis\/jiv530","article-title":"Strategies for Improving Polio Surveillance Performance in the Security-Challenged Nigerian States of Adamawa, Borno, and Yobe During 2009\u20132014","volume":"213","author":"Hamisu","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/infdis\/jiu022","article-title":"Polio eradication initiative in Afghanistan, 1997\u20132013","volume":"210","author":"Simpson","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/infdis\/jiu450","article-title":"Progress and peril: Poliomyelitis eradication efforts in Pakistan, 1994\u20132013","volume":"210","author":"Alexander","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_84","first-page":"973","article-title":"Progress toward poliomyelitis eradication\u2014Afghanistan and Pakistan, January 2013\u2013August 2014","volume":"63","author":"Farag","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/risa.12962","article-title":"Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations","volume":"38","author":"Pallansch","year":"2018","journal-title":"Risk Anal."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6441a2","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2014\u2013August 2015","volume":"64","author":"Mbaeyi","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.15585\/mmwr.mm6543a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2015\u2013August 2016","volume":"65","author":"Mbaeyi","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"854","DOI":"10.15585\/mmwr.mm6632a5","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2016\u2013June 2017","volume":"66","author":"Martinez","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.15585\/mmwr.mm6730a6","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2017\u2013May 2018","volume":"67","author":"Martinez","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"729","DOI":"10.15585\/mmwr.mm6833a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2018\u2013May 2019","volume":"68","author":"Martinez","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.15585\/mmwr.mm6940a3","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2019\u2013July 2020","volume":"69","author":"Martinez","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15585\/mmwr.mm7103a3","article-title":"Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2020\u2013November 2021","volume":"71","author":"Sadigh","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.038","article-title":"The resurgence of wild poliovirus in Pakistan and Afghanistan: A new setback for polio eradication","volume":"85","author":"Rana","year":"2022","journal-title":"J. Infect."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.15585\/mmwr.mm7034a1","article-title":"Progress Toward Polio Eradication\u2014Worldwide, January 2019\u2013June 2021","volume":"70","author":"Bigouette","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2471\/BLT.09.066480","article-title":"Pakistan, politics and polio","volume":"88","author":"Nishtar","year":"2010","journal-title":"Bull. World Health Organ."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12992-016-0195-3","article-title":"Eradicating polio in Pakistan: An analysis of the challenges and solutions to this security and health issue","volume":"12","author":"Hussain","year":"2016","journal-title":"Glob. Health"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(13)60764-3","article-title":"Poliomyelitis in Pakistan: Time for the Muslim world to step in","volume":"381","author":"Ahmed","year":"2013","journal-title":"Lancet"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1057\/s41271-016-0056-6","article-title":"Knowledge and perceptions of polio and polio immunization in polio high-risk areas of Pakistan","volume":"38","author":"Habib","year":"2017","journal-title":"J. Public Health Policy"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Habib, M.A., Tabassum, F., Hussain, I., Khan, T.J., Syed, N., Shaheen, F., Soofi, S.B., and Bhutta, Z.A. (2023). Exploring Knowledge and Perceptions of Polio Disease and Its Immunization in Polio High-Risk Areas of Pakistan. Vaccines, 11.","DOI":"10.3390\/vaccines11071206"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1093\/infdis\/jit816","article-title":"Lot quality assurance sampling to monitor supplemental immunization activity quality: An essential tool for improving performance in polio endemic countries","volume":"210","author":"Brown","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_101","unstructured":"Centers for Disease Control and Prevention (2013). Progress Toward Poliomyelitis Eradication\u2014Afghanistan, January 2012\u2013September 2013. MMWR Morb. Mortal. Wkly. Rep., 62, 928\u2013933."},{"key":"ref_102","unstructured":"Centers for Disease Control and Prevention (2005). Progress toward poliomyelitis eradication\u2014Afghanistan and Pakistan, January 2004\u2013February 2005. MMWR Morb. Mortal. Wkly. Rep., 54, 276\u2013279."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(22)01806-2","article-title":"Afghanistan\u2019s health system under the Taliban: Key challenges","volume":"400","author":"Safi","year":"2022","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1093\/infdis\/jiae129","article-title":"Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan","volume":"231","author":"Sabawoon","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6445a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2014\u2013September 2015","volume":"64","author":"Farag","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.15585\/mmwr.mm6646a4","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2016\u2013September 2017","volume":"66","author":"Elhamidi","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.15585\/mmwr.mm6744a5","article-title":"Progress Toward Poliomyelitis Eradication\u2014Pakistan, January 2017\u2013September 2018","volume":"67","author":"Hsu","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Noor, A.M. (2022). Country ownership in global health. PLOS Glob. Public Health, 2.","DOI":"10.1371\/journal.pgph.0000113"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: Implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jama.1996.03530450029028","article-title":"Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States","volume":"275","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/jvi.33.1.256-263.1980","article-title":"Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus","volume":"33","author":"Kew","year":"1980","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"ref_113","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: Current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_115","unstructured":"Centers for Disease Control and Prevention (2007). Update on vaccine-derived polioviruses\u2014Worldwide, January 2006\u2013August 2007. MMWR Morb. Mortal. Wkly. Rep., 56, 996\u20131001."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Estivariz, C.F., Krow-Lucal, E.R., and Mach, O. (2024). Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management. Pathogens, 13.","DOI":"10.3390\/pathogens13121128"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2007.03.009","article-title":"Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child","volume":"127","author":"Adu","year":"2007","journal-title":"Virus Res."},{"key":"ref_118","unstructured":"Global Polio Eradication Initiative (2025, September 04). Classification and Reporting of Vaccine-Derived Polioviruses (VDPVs). Available online: http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/09\/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.02954-12","article-title":"Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria","volume":"87","author":"Burns","year":"2013","journal-title":"J. Virol."},{"key":"ref_121","unstructured":"Centers for Disease Control and Prevention (2009). Update on Vaccine-Derived Polioviruses\u2014Worldwide, January 2008\u2013June 2009. MMWR Morb. Mortal. Wkly. Rep., 58, 1002\u20131006."},{"key":"ref_122","unstructured":"Centers for Disease Control and Prevention (2011). Update on Vaccine-Derived Polioviruses\u2014Worldwide, July 2009\u2013March 2011. MMWR Morb. Mortal. Wkly. Rep., 60, 846\u2013850."},{"key":"ref_123","unstructured":"Centers for Disease Control and Prevention (2009). Progress Toward Poliomyelitis Eradication\u2014Nigeria, January 2008\u2013July 2009. MMWR Morb. Mortal. Wkly. Rep., 58, 1150\u20131154."},{"key":"ref_124","unstructured":"Centers for Disease Control and Prevention (2012). Update on vaccine-derived polioviruses\u2014Worldwide, April 2011\u2013June 2012. MMWR Morb. Mortal. Wkly. Rep., 61, 741\u2013746."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.vaccine.2023.02.042","article-title":"Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017\u20132021","volume":"41","author":"Alleman","year":"2023","journal-title":"Vaccine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: A case-control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: Review of past experiences and their potential use after polio eradication","volume":"33","author":"Caceres","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","unstructured":"Centers for Disease Control and Prevention (2006). Progress toward poliomyelitis eradication\u2014India, January 2005\u2013June 2006. MMWR Morb. Mortal. Wkly. Rep., 55, 772\u2013776."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: A randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"ref_131","unstructured":"World Health Organization (2010). Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, November 2009. Special consultation with polio-infected countries and global management team partners, Geneva, 18\u201319 November 2009. Wkly. Epidemiol. Rec., 85, 1\u201311."},{"key":"ref_132","first-page":"1031","article-title":"Possible eradication of wild poliovirus type 3\u2014Worldwide, 2012","volume":"63","author":"Kew","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_133","unstructured":"Centers for Disease Control and Prevention (2011). Progress toward poliomyelitis eradication\u2014-India, January 2010\u2013September 2011. MMWR Morb. Mortal. Wkly. Rep., 60, 1482\u20131486."},{"key":"ref_134","unstructured":"World Health Organization (2013). Meeting of the Strategic Advisory Group of Experts on immunization, November 2012\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 88, 1\u201316."},{"key":"ref_135","unstructured":"World Health Organization (2012). Meeting of the Strategic Advisory Group of Experts on immunization, April 2012\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 87, 201\u2013216."},{"key":"ref_136","unstructured":"World Health Organization (2013). Meeting of the Strategic Advisory Group of Experts on immunization, April 2013\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 88, 201\u2013216."},{"key":"ref_137","unstructured":"World Health Organization (2014). Meeting of the StrategicAdvisory Group of Experts on immunization, November 2013\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 89, 1\u201319."},{"key":"ref_138","unstructured":"World Health Organization (2014). Meeting of the Strategic Advisory Group of Expert on immunization, April 2014\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 89, 211\u2013236."},{"key":"ref_139","unstructured":"World Health Organization (2014). Meeting of the Strategic Advisory Group of Experts on immunization, October 2014\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 89, 561\u2013576."},{"key":"ref_140","unstructured":"World Health Organization (2015). Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: Conclusions and recommendations. Wkly. Epidemiol. Rec., 90, 261\u2013276."},{"key":"ref_141","unstructured":"World Health Organization (2015). Meeting of the Strategic Advisory Group of Experts on immunization, October 2015\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 90, 681\u2013699."},{"key":"ref_142","unstructured":"World Health Organization (2016). Meeting of the Strategic Advisory Group of Experts on immunization, April 2016\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 91, 266\u2013284."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/jix108","article-title":"Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission","volume":"216","author":"Thompson","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(21)00453-9","article-title":"Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: A retrospective analysis of surveillance data for 51 countries in Africa","volume":"22","author":"Cooper","year":"2022","journal-title":"Lancet. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"A122","DOI":"10.1016\/j.vaccine.2022.02.050","article-title":"Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience","volume":"41","author":"Macklin","year":"2023","journal-title":"Vaccine"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: The epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_147","unstructured":"Centers for Disease Control and Prevention (2001). Public Health Dispatch: Update: Outbreak of Poliomyelitis\u2014Dominican Republic and Haiti, 2000\u20132001. MMWR Morb. Mortal. Wkly. Rep., 50, 855\u2013856."},{"key":"ref_148","unstructured":"Centers for Disease Control and Prevention (2006). Update on Vaccine-Derived Polioviruses. MMWR Morb. Mortal. Wkly. Rep., 55, 1093\u20131097."},{"key":"ref_149","first-page":"242","article-title":"Update on Vaccine-Derived Polioviruses-Worldwide, July 2012\u2013December 2013","volume":"63","author":"Diop","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_150","first-page":"640","article-title":"Update on Vaccine-Derived Polioviruses-Worldwide, January 2014\u2013March 2015","volume":"64","author":"Diop","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on Vaccine-Derived Polioviruses-Worldwide, January 2015\u2013May 2016","volume":"65","author":"Jorba","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6742a5","article-title":"Update on Vaccine-Derived Polioviruses-Worldwide, January 2017\u2013June 2018","volume":"67","author":"Jorba","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.15585\/mmwr.mm6845a4","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2018\u2013June 2019","volume":"68","author":"Jorba","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm6916a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, July 2019\u2013February 2020","volume":"69","author":"Alleman","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.15585\/mmwr.mm7214a3","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2021\u2013December 2022","volume":"72","author":"Bigouette","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1016\/j.vaccine.2016.10.017","article-title":"Measuring polio immunity to plan immunization activities","volume":"34","author":"Voorman","year":"2016","journal-title":"Vaccine"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1016\/j.vaccine.2017.08.063","article-title":"Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo","volume":"35","author":"Voorman","year":"2017","journal-title":"Vaccine"},{"key":"ref_158","unstructured":"Centers for Disease Control and Prevention (2001). Circulation of a type 2 vaccine-derived poliovirus\u2014Egypt, 1982\u20131993. Morb. Mortal. Wkly. Rep., 50, 41\u201351."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","article-title":"Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993","volume":"77","author":"Yang","year":"2003","journal-title":"J. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3201\/eid0907.020692","article-title":"Recombinant vaccine-derived poliovirus in Madagascar","volume":"9","author":"Rousset","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/587694","article-title":"Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar","volume":"197","author":"Gumede","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"770","DOI":"10.15585\/mmwr.mm6530a4","article-title":"Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission-Nigeria, 2016","volume":"65","author":"Etsano","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7133e2","article-title":"Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater-New York, June\u2013August 2022","volume":"71","author":"Lutterloh","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.vaccine.2023.02.043","article-title":"Linked poliovirus incidents in the UK, USA and Israel: Silent transmission or missed warnings of vaccine inequity?","volume":"1","author":"Kasstan","year":"2023","journal-title":"Vaccine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(22)01804-9","article-title":"Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance","volume":"400","author":"Klapsa","year":"2022","journal-title":"Lancet"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Seo, G.E., Mandes, R., Wright, N.D., Hawkins, J.P., Landgraff, A., Lidder, R., Mohammed, U., Mangat, C.S., Michel, A.S., and Fafard, J. (2025). Sporadic detection of vaccine-derived poliovirus type 2 using next-generation sequencing in Canadian wastewater in August of 2022. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-92912-x"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"103136","DOI":"10.1016\/j.eclinm.2025.103136","article-title":"Public health, war and cross-border challenges: The recent cVDPV2 polio outbreak in Gaza","volume":"81","author":"Grotto","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"122","DOI":"10.15585\/mmwr.mm7407a4","article-title":"Notes from the Field: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater-Five European Countries, September-December 2024","volume":"74","author":"Huseynov","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_169","unstructured":"Global Polio Eradication Initiative (2025, September 04). Kingdom of Saudi Arabia confirms US$500 Million Commitment to Global Polio Eradication Effort. 2025. Press Release 24 February. Available online: https:\/\/polioeradication.org\/news\/kingdom-of-saudi-arabia-confirms-us-500-million-commitment-to-global-polio-eradication-effort\/."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Guarino, K., Voorman, A., Gasteen, M., Stewart, D., and Wenger, J. (2017). Violence, insecurity, and the risk of polio: A systematic analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185577"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e20489","DOI":"10.1016\/j.heliyon.2023.e20489","article-title":"Violent crimes and insecurity on Nigerian highways: A tale of travelers\u2019 trauma, nightmares and state slumber","volume":"9","author":"Ugwuoke","year":"2023","journal-title":"Heliyon"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2237390","DOI":"10.1080\/21645515.2023.2237390","article-title":"Polio vaccination activities in conflict-affected areas","volume":"19","author":"Mbaeyi","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"575","DOI":"10.15585\/mmwr.mm7325a2","article-title":"Persistent Transmission of Circulating Vaccine-Derived Poliovirus-Somalia, January 2017\u2013March 2024","volume":"73","author":"Mendes","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_174","unstructured":"World Health Organization (2025, September 04). Mass Polio Vaccination Campaign to Continue in the Gaza Strip. Press Release 19 February. Available online: https:\/\/www.who.int\/news\/item\/19-02-2025-mass-polio-vaccination-campaign-to-continue-in-the-gaza-strip."},{"key":"ref_175","unstructured":"British Broadcasting Corporation (2025, September 04). Israel Agrees to Pauses in Fighting for Polio Vaccine Drive. Available online: https:\/\/www.bbc.com\/news\/articles\/cn02z5kjn40o."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Gammino, V.M., Diaz, M.R., Pallas, S.W., Greenleaf, A.R., and Kurnit, M.R. (2020). Health services uptake among nomadic pastoralist populations in Africa: A systematic review of the literature. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008474"},{"key":"ref_177","unstructured":"Centers for Disease Control and Prevention (2013). Polio field census and vaccination of underserved populations\u2014Northern Nigeria, 2012\u20132013. MMWR Morb. Mortal. Wkly. Rep., 62, 663\u2013665."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/infdis\/jiu199","article-title":"Polio eradication in Nigeria and the role of the National Stop Transmission of Polio program, 2012\u20132013","volume":"210","author":"Waziri","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/infdis\/jiu197","article-title":"Outreach to underserved communities in northern Nigeria, 2012\u20132013","volume":"210","author":"Gidado","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1016\/j.vaccine.2022.02.022","article-title":"Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019\u20132021","volume":"41","author":"Snider","year":"2023","journal-title":"Vaccine"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2214-109X(17)30184-5","article-title":"Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: A cluster randomised controlled trial","volume":"5","author":"Habib","year":"2017","journal-title":"Lancet. Glob. Health"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2465645","DOI":"10.1080\/17441692.2025.2465645","article-title":"Engage less, provide more: Community health workers\u2019 perspectives on how to overcome opposition to polio vaccination in Pakistan","volume":"20","author":"Majidulla","year":"2025","journal-title":"Glob. Public Health"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/infdis\/jiv511","article-title":"Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013\u20132014","volume":"213","author":"Warigon","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1498016","DOI":"10.3389\/fpubh.2024.1498016","article-title":"Community acceptance of services and effectiveness of health camps in high-risk areas of Karachi, Sindh, Pakistan, 2021","volume":"12","author":"Abbasi","year":"2024","journal-title":"Front Public Health"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Lassi, Z.S., Naseem, R., Salam, R.A., Siddiqui, F., and Das, J.K. (2021). The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18030988"},{"key":"ref_186","unstructured":"World Health Organization (2021). Meeting of the Strategic Advisory Group of Experts on immunization, October 2021: Conclusions and recommendations. Wkly. Epidemiol. Rec., 96, 613\u2013632."},{"key":"ref_187","unstructured":"Lush, L., Attfield, W., Baxendale, J., Vuylsteke, Y., McPherson, S., Rutherford, S., Page, P., Weil, C., Maynard, C., and Kastritis, P. (2024). Evaluation of Gavi\u2019s Contribution to Reaching Zero-Dose and Missed Communities: Year 1 Annual Report, Gavi. Available online: https:\/\/www.gavi.org\/sites\/default\/files\/evaluations\/ZD-Evaluation_Year-1_Final%20Report.pdf."},{"key":"ref_188","unstructured":"World Health Organization, UNICEF, Gavi, and Bill & Melinda Gates Foundation (2025, September 04). Global Partners Announce a New Effort\u2014\u201cThe Big Catch-Up\u201d\u2014To Vaccinate Millions of Children and Restore Immunization Progress Lost During the Pandemic. Press Release 24 April. Available online: https:\/\/www.who.int\/news\/item\/24-04-2023-global-partners-announce-a-new-effort-the-big-catch-up-to-vaccinate-millions-of-children-and-restore-immunization-progress-lost-during-the-pandemic."},{"key":"ref_189","unstructured":"Gavi, and The Vaccine Initiative (2025, September 04). One Year of the Big Catch-Up: What Progress Has Been Made?. Available online: https:\/\/www.gavi.org\/vaccineswork\/one-year-big-catch-what-progress."},{"key":"ref_190","unstructured":"World Health Organization, and UNICEF (2025, September 04). Global Childhood Vaccination Coverage Holds Steady, yet over 14 Million Infants Remain Unvaccinated\u2013WHO, UNICEF. Press Release 15 July. Available online: https:\/\/www.who.int\/news\/item\/15-07-2025-global-childhood-vaccination-coverage-holds-steady-yet-over-14-million-infants-remain-unvaccinated-who-unicef."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1016\/j.vaccine.2023.02.060","article-title":"Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020","volume":"41","author":"Darwar","year":"2023","journal-title":"Vaccine"},{"key":"ref_192","unstructured":"Geiger, K., Heaghney, N., Bigouette, J.P., Bennett, S.D., Kovacs, S.D., and Wassilak, S.G.F. (2024, January 23\u201326). Supplemental Immunization Activity Response Timeliness for Circulating Vaccine-Derived Poliovirus Outbreaks\u2014Worldwide, 2016\u20132023. Proceedings of the Epidemic Intelligence Service Conference 2024, Atlanta, GA, USA. Available online: https:\/\/stacks.cdc.gov\/view\/cdc\/154509\/cdc_154509_DS1.pdf."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1539-6924.2006.00843.x","article-title":"Evaluation of response scenarios to potential polio outbreaks using mathematical models","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Anal."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41564-023-01453-4","article-title":"Sensitive poliovirus detection using nested PCR and nanopore sequencing: A prospective validation study","volume":"8","author":"Shaw","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Ueno, M.K., Kitamura, K., Nishimura, Y., and Arita, M. (2023). Evaluation of Direct Detection Protocols for Poliovirus from Stool Samples of Acute Flaccid Paralysis Patients. Viruses, 15.","DOI":"10.3390\/v15102113"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"114914","DOI":"10.1016\/j.jviromet.2024.114914","article-title":"Validation of improved automated nucleic acid extraction methods for direct detection of polioviruses for global polio eradication","volume":"326","author":"Miles","year":"2024","journal-title":"J. Virol. Methods"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Marcet, P.L., Short, B., Deas, A., Sun, H., Harrington, C., Shaukat, S., Alam, M.M., Baba, M., Faneye, A., and Namuwulya, P. (2025). Advancing poliovirus eradication: Lessons learned from piloting direct molecular detection of polioviruses in high-risk and priority geographies. Microbiol. Spectr., 13.","DOI":"10.1128\/spectrum.02279-24"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm6533a5","article-title":"Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign-Telangana State, India, June 2016","volume":"65","author":"Bahl","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.15585\/mmwr.mm6647a4","article-title":"Fractional-Dose Inactivated Poliovirus Vaccine Campaign-Sindh Province, Pakistan, 2016","volume":"66","author":"Pervaiz","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3201\/eid2411.180050","article-title":"Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014\u20132017","volume":"24","author":"Grassly","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(21)00497-6","article-title":"Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: A pragmatic, open-label, non-inferiority trial in The Gambia","volume":"10","author":"Bashorun","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.15585\/mmwr.mm7247a3","article-title":"Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine-Sokoto State, Nigeria, November 2022","volume":"72","author":"Biya","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"A113","DOI":"10.1016\/j.vaccine.2022.03.027","article-title":"Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks","volume":"41","author":"Estivariz","year":"2023","journal-title":"Vaccine"},{"key":"ref_204","unstructured":"World Health Organization (2024). Meeting of the Strategic Advisory Group of Experts on immunization, September 2024\u2014Conclusions and recommendations. Wkly. Epidemiol. Rec., 99, 719\u2013740."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global polio eradication initiative: Lessons learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_206","unstructured":"Centers for Disease Control and Prevention (2013). Assessing the Risks for Poliovirus Outbreaks in Polio-Free Countries\u2014Africa, 2012\u20132013. MMWR Morb. Mortal. Wkly. Rep., 62, 768\u2013772."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2022.03.013","article-title":"Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine","volume":"41","author":"Voorman","year":"2023","journal-title":"Vaccine"},{"key":"ref_208","first-page":"366","article-title":"Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences","volume":"44","author":"Kalkowska","year":"2023","journal-title":"Risk Anal. Off. Publ. Soc. Risk Anal."},{"key":"ref_209","unstructured":"Global Polio Eradication Initiative (2024). Polio Eradication Strategy 2022\u20132026: Delivering on a Promise, Extension to 2029, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/382399\/9789240109506-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_210","unstructured":"Global Polio Eradication Initiative (2025, September 04). WHO Executive Board Says Emergency Measures Needed to Stop Polio: Global Polio and Health Experts Urge Right Geopolitical Decisions to Stop \u2018Perfect Storm\u2019 for Poliovirus Transmission and Protect Eradication. Press Release 7 February 2025. Available online: https:\/\/polioeradication.org\/news\/who-executive-board-says-emergency-measures-needed-to-stop-polio\/."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/risa.13193","article-title":"Environmental Surveillance System Characteristics and Impacts on Confidence About No Undetected Serotype 1 Wild Poliovirus Circulation","volume":"39","author":"Kalkowska","year":"2019","journal-title":"Risk Anal."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Kroiss, S.J., Ahmadzai, M., Ahmed, J., Alam, M.M., Chabot-Couture, G., Famulare, M., Mahamud, A., McCarthy, K.A., Mercer, L.D., and Muhammad, S. (2018). Assessing the sensitivity of the polio environmental surveillance system. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208336"},{"key":"ref_213","unstructured":"Global Polio Eradication Initiative (2022). Global Polio Surveillance Action Plan, 2022\u20132024, World Health Organization. Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/05\/GPSAP-2022-2024-EN.pdf."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Pons-Salort, M., Molodecky, N.A., O\u2019Reilly, K.M., Wadood, M.Z., Safdar, R.M., Etsano, A., Vaz, R.G., Jafari, H., Grassly, N.C., and Blake, I.M. (2016). Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002140"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Molodecky, N.A., Blake, I.M., O\u2019Reilly, K.M., Wadood, M.Z., Safdar, R.M., Wesolowski, A., Buckee, C.O., Bandyopadhyay, A.S., Okayasu, H., and Grassly, N.C. (2017). Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002323"},{"key":"ref_216","first-page":"1059","article-title":"Progress toward poliomyelitis eradication\u2014Nigeria, January 2013\u2013September 2014","volume":"63","author":"Etsano","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.adu6580","article-title":"Global withdrawal of Sabin oral poliovirus type 2 vaccine in 2016","volume":"387","author":"Molodecky","year":"2025","journal-title":"Science"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Pons-Salort, M., Burns, C.C., Lyons, H., Blake, I.M., Jafari, H., Oberste, M.S., Kew, O.M., and Grassly, N.C. (2016). Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005728"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1093\/infdis\/jiae614","article-title":"Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series Analysis","volume":"231","author":"Cooper","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Peak, C.M., Lyons, H., Voorman, A., Gray, E.J., Cooper, L.V., Blake, I.M., Hawes, K.M., and Bandyopadhyay, A.S. (2024). Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine. Vaccines, 12.","DOI":"10.1101\/2024.10.16.24315616"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.15585\/mmwr.mm7238a4","article-title":"Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use-Six African Countries, 2021\u20132023","volume":"72","author":"Davlantes","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Castro, C.J., Oderinde, B.S., Poston, K.D., Mawashi, K.Y., Bullard, K., Akinola, M., Meade, C., Liu, H., Hu, F., and Bullows, J.E. (2024). Complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from Nigeria 2023\u20132024. Microbiol. Resour. Announc., 13.","DOI":"10.1128\/mra.00881-24"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Thompson, K.M., Kalkowska, D.A., and Badizadegan, K. (2023). Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1098419"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: An economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"key":"ref_225","first-page":"334","article-title":"Economic analysis of the global polio eradication initiative","volume":"29","author":"Pallansch","year":"2011","journal-title":"Vaccine"},{"key":"ref_226","first-page":"561","article-title":"Projection of Costs of Polio Eradication Compared to Permanent Control","volume":"221","author":"Zimmermann","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_227","first-page":"393","article-title":"An Updated Economic Analysis of the Global Polio Eradication Initiative","volume":"41","author":"Thompson","year":"2021","journal-title":"Risk Anal. Off. Publ. Soc. Risk Anal."}],"updated-by":[{"DOI":"10.3390\/vaccines13121217","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000}}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/10\/1060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:19:58Z","timestamp":1764595198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/10\/1060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":227,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["vaccines13101060"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13101060","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}